Nutrients & HIV Newsletter 
Vol 1. 07
January 2007  
Dear Doctor,

Welcome to this month's edition of Nutrients & HIV newsletter. To unsubscribe please click the email address at the bottom of the page and send a blank email to us.

Due to the large number of requests on previous issues of this newletter, we have posted all the previous issues on our website and can be accessed at www.lighthousepharma.com/immunace.htm

  In this issue: Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension.
 
 J Nutr. 2005 Jul;135(7):1776-81.  

Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension

  • Merchant AT,
  • Msamanga G,
  • Villamor E,
  • Saathoff E,
  • O'brien M,
  • Hertzmark E,
  • Hunter DJ,
  • Fawzi WW.

Population Health Research Institute and McMaster University, Hamilton ON, Canada. anwar.merchant@post.harvard.edu

Hypertension during pregnancy increases fetal growth retardation, preterm deliveries, and perinatal deaths, and yet its causes remain unclear. 

In HIV-infected women, preterm birth additionally increases the risk of HIV transmission to the infant. Oxidative stress and endothelial cell dysfunction of the placenta have been implicated in the development of hypertension during pregnancy. Vitamin intake can reduce oxidative stress and improve endothelial function. 

We therefore evaluated the effect of multivitamin (20 mg thiamine, 20 mg riboflavin, 25 mg B-6, 50 microg B-12, 500 mg C, 30 mg E, and 0.8 mg folic acid) and vitamin A supplements (30 mg beta-carotene plus 5000 IU preformed vitamin A) in relation to hypertension during pregnancy (systolic blood pressure > or = 140 mm Hg or diastolic blood pressure > or = 90 mm Hg at any time during pregnancy). 

In a double-blind, placebo-controlled, randomized, clinical trial, conducted among 1078 HIV-positive pregnant Tanzanian women, those who received multivitamins were 38% less likely to develop hypertension during pregnancy than those who did not [relative risk (RR) = 0.62, 95% CI 0.40-0.94, P = 0.03]. There was no overall effect of vitamin A on hypertension during pregnancy (RR = 1.00, 95% CI 0.66-1.51, P = 0.98). Hypertension during pregnancy was more likely in women with high baseline systolic blood pressure (>120 vs. < or = 120 mm Hg) (RR = 6.02, 95%CI 2.59-13.97, P < 0.001), and those with higher mid-upper arm circumference (RR = 1.12, 95% CI 1.04-1.19, P = 0.002). 

Taking multivitamins containing vitamins B, C, and E during pregnancy may be an inexpensive and effective strategy to improve the health of the mother and baby.

Full article available on request... reply on same address with subject title, "article"

 

NEW!  ----- IMMUNACE tablets
IMMUNACE is a comprehensive spectrum of 22 antioxidant, vitamins and essential nutrients specifically designed to help maintain immune resistance and long-term cell protection. 

It is the ONLY product in this category with a clinical trial that has been published in a reputable medical journal - AIDS (The Official Journal of International AIDS Society). www.aidsonline.com. IMMUNACE has been studied in an independent double blind cross-over study. World-renowned institution the London School of Hygiene and Tropical Medicine, University of London, conducted the published trial. Trial participants were followed up every 12 weeks for a total of 48 weeks during which a statistically significant benefit was found in the group taking IMMUNACE. Click here for more details.

IMMUNACE IS NOT A REPLACEMENT FOR ARV TREATMENT OR BALANCED DIET. IT COMPLEMENTS HIV/AIDS MANAGEMENT DUE TO THE HIGH NUTRITIONAL REQUIREMENTS OF THESE PATIENTS

IMMUNACE is currently approved for reimbursement to HIV/AIDS patients in the following medical aid schemes:

  • Aid for Aids patients (MedScheme now Solutio) i.e. Bonitas, GEMS, Liberty, Medshield, etc
  • Status Medical Aid Administrators i.e. Protea Medical Aid, Grintek, Lifemed, Compcare, Goodhope etc

Old!

Immunace 30 Capsules


New! 

 Immunace 30 Tablets

 
Lighthouse Pharma
Tel: +27-11-392 4307
Cell: +27-72-048 1199
Fax: +27-11-825 7663
Visit: www.lighthousepharma.com
Email: admin@lighthousepharma.com
Member Services
1. We respect your privacy. If you would prefer not to receive this newsletter or emails,  just reply a blank email to this address: unsubscribe@lighthousepharma.com
2. If you have any questions and would like to contact us then please e-mail us at immunace@lighthousepharma.com or visit http://www.immunace.com for detailed product information